Markers of inflammation in men with small abdominal aortic aneurysm

Journal of Vascular Surgery

Volumn 52, Issue 1, 2010, Pages 145-151

  Parry, Duncan J ^a,b   Al Barjas, Hamad S ^c   Chappell, Louise ^c   Rashid, S Tawqeer ^a,c   Ariëns, Robert A S ^a   Scott, D Julian A ^a,c  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b CALDERDALE AND HUDDERSFIELD NHS FOUNDATION TRUST   (United Kingdom)

^c LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3; D DIMER; FIBRINOGEN; INTERLEUKIN 6;

ABDOMINAL AORTA ANEURYSM; AGED; AORTA; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; COMPARATIVE STUDY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE COURSE; FIBRINOGEN BLOOD LEVEL; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; ULTRASOUND;

AGED; AORTIC ANEURYSM, ABDOMINAL; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; COMPLEMENT C3; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; LINEAR MODELS; MALE; UP-REGULATION;

EID: 77953661124     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2010.02.279     Document Type: Article

References (40)

1. Jagedashan V.P., Scott D.J.A., and Carding S.R. Abdominal aortic aneurysms; an auto-immune disease?. Trends Molec Med 14 (2008) 522-529
2. Marian A.J. On genetics, inflammation, and abdominal aortic aneurysm: can single nucleotide polymorphisms predict the outcome?. Circulation 103 (2001) 2222-2224
3. Jones K.G., Brull D.J., Brown L.C., Sian M., Greenhalgh R.M., Humphries S.E., et al. Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation 103 (2001) 2260-2265
4. Dawson J., Cockerill G.W., Choke E., Belli A.M., Loftus I., and Thompson M.M. Aortic aneurysms secrete interleukin-6 into the circulation. J Vasc Surg 45 (2007) 350-356
5. Hu C.H., Harris J.E., Davie E.W., and Chung D.W. Characterization of the 5′-flanking region of the gene for the alpha chain of human fibrinogen. J Biol Chem 270 (1995) 28342-28349
6. Latkovskis G., Licis N., and Kalnins U. C-reactive protein levels and common polymorphisms of the interleukin-1 gene cluster and interleukin-6 gene in patients with coronary heart disease. Eur J Immunogenet 31 (2004) 207-213
7. Forester N.D., Cruickshank S.M., Scott D.J., and Carding S.R. Increased natural killer cell activity in patients with an abdominal aortic aneurysm. Br J Surg 93 (2006) 46-54
8. Vainas T., Lubbers T., Stassen F.R., Herngreen S.B., Dieijen-Visser M.P., Bruggeman C.A., et al. Serum C-reactive protein level is associated with abdominal aortic aneurysm size and may be produced by aneurysmal tissue. Circulation 107 (2003) 1103-1105
9. Wanhainen A., Bergqvist D., Boman K., Nilsson T.K., Rutegard J., and Bjorck M. Risk factors associated with abdominal aortic aneurysm: a population-based study with historical and current data. J Vasc Surg 41 (2005) 390-396
10. Norman P., Spencer C.A., Lawrence-Brown M.M., and Jamrozik K. C-reactive protein levels and the expansion of screen-detected abdominal aortic aneurysms in men. Circulation 110 (2004) 862-866
11. Levi M., van der P.T., and Buller H.R. Bidirectional relation between inflammation and coagulation. Circulation 109 (2004) 2698-2704
12. Carroll M.C. The complement system in regulation of adaptive immunity. Nat Immunol 5 (2004) 981-986
13. Shats-Tseytlina E.A., Nair C.H., and Dhall D.P. Complement activation: a new participant in the modulation of fibrin gel characteristics and the progression of atherosclerosis?. Blood Coagul Fibrinolysis 5 (1994) 529-535
14. Libby P. Multiple mechanisms of thrombosis complicating atherosclerotic plaques. Clin Cardiol 23 suppl 6 (2000) VI-7
15. Yamazumi K., Ojiro M., Okumura H., and Aikou T. An activated state of blood coagulation and fibrinolysis in patients with abdominal aortic aneurysm. Am J Surg 175 (1998) 297-301
16. Nomura F., Ihara A., Yoshitatsu M., Tamura K., Katayama A., and Ihara K. Relationship between coagulation cascade, cytokine, adhesion molecule and aortic aneurysm. Eur J Cardiothorac Surg 23 (2003) 1034-1038
17. Fowkes F.G., Anandan L.C., Lee A.J., Smith F.B., Tzoulaki I., Rumley A., et al. Reduced lung fuction in patients with abdominal aortic aneurysm is associated with activation of inflammation and hemostasis, not smoking or cardiovascular disease. J Vasc Surg 43 (2006) 474-480
18. Houard X., Rouzet F., Touat Z., Philippe M., Dominguez M., Fontaine V., et al. Topology of the fibrinolytic system within the mural thrombus of human abdominal aortic aneurysms. J Pathol 212 (2007) 20-28
19. Parry D.J., Al-Barjas H.S., Chappell L., Rashid T., Ariens R.A., and Scott D.J. Haemostatic and fibrinolytic factors in men with a small abdominal aortic aneurysm. Br J Surg 96 (2009) 870-877
20. Ritchie D.G., Levy B.A., Adams M.A., and Fuller G.M. Regulation of fibrinogen synthesis by plasmin-derived fragments of fibrinogen and fibrin: an indirect feedback pathway. Proc Natl Acad Sci U S A 79 (1982) 1530-1534
21. Robson S.C., Shephard E.G., and Kirsch R.E. Fibrin degradation product D-dimer induces the synthesis and release of biologically active IL-1 beta, IL-6 and plasminogen activator inhibitors from monocytes in vitro. Br J Haematol 86 (1994) 322-326
22. Edgington T.S., Curtiss L.K., and Plow E.F. A linkage between the hemostatic and immune systems embodied in the fibrinolytic release of lymphocyte suppressive peptides. J Immunol 134 (1985) 471-477
23. Sprouse L.R., Meier III G.H., Parent F.N., DeMasi R.J., Glickman M.H., and Barber G.A. Is ultrasound more accurate than axial computed tomography for determination of maximal abdominal aortic aneurysm diameter?. Eur J Vasc Endovasc Surg 28 (2004) 28-35
24. Lederle F.A., Johnson G.R., Wilson S.E., Gordon I.L., Chute E.P., Littooy F.N., et al. Relationship of age, gender, race, and body size to infrarenal aortic diameter. The Aneurysm Detection and Management (ADAM) Veterans Affairs Cooperative Study Investigators. J Vasc Surg 26 (1997) 595-601
25. Ashton H.A., Buxton M.J., Day N.E., Kim L.G., Marteau T.M., Scott R.A., et al. The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Lancet 360 (2002) 1531-1539
26. Registrar General. Mortality statistics. Cause. Review of the Registrar General on deaths by cause, sex and age in England and Wales, 2005 (2006), Office for National Statistics, London Series DH2 No. 32, 98
27. Brady A.R., Fowkes F.G., Greenhalgh R.M., Powell J.T., Ruckley C.V., and Thompson S.G. Risk factors for postoperative death following elective surgical repair of abdominal aortic aneurysm: results from the UK Small Aneurysm Trial. On behalf of the UK Small Aneurysm Trial participants. Br J Surg 87 (2000) 742-749
28. Greenhalgh R.M., Brown L.C., Kwong G.P., Powell J.T., and Thompson S.G. Comparison of endovascular aneurysm repair with open repair in patients with abdominal aortic aneurysm (EVAR trial 1), 30-day operative mortality results: randomised controlled trial. Lancet 364 (2004) 843-848
29. Lowe G.D., Sweetnam P.M., Yarnell J.W., Rumley A., Rumley C., Bainton D., et al. C-reactive protein, fibrin D-dimer, and risk of ischemic heart disease: the Caerphilly and Speedwell studies. Arterioscler Thromb Vasc Biol 24 (2004) 1957-1962
30. Hosaka A., Miyata T., Aramoto H., Shigematsu H., Nakazawa T., Okamoto H., et al. Clinical implication of plasma level of soluble fibrin monomer-fibrinogen complex in patients with abdominal aortic aneurysm. J Vasc Surg 42 (2005) 200-205
31. Shantikumar S., Ajjan R., Porter K.E., and Scott D.J. Diabetes and the Abdominal Aortic Aneurysm. Eur J Vasc Endovasc Surg 39 2 (2010) 200-207
32. Krupinski J., Turu M.M., Martinez-Gonzalez J., Carvajal A., Juan-Babot J.O., Iborra E., et al. Endogenous expression of C-reactive protein is increased in active (ulcerated noncomplicated) human carotid artery plaques. Stroke 37 (2006) 1200-1204
33. Wilson A.M., Swan J.D., Ding H., Zhang Y., Whitbourn R.J., Gurry J., et al. Widespread vascular production of C-reactive protein (CRP) and a relationship between serum CRP, plaque CRP and intimal hypertrophy. Atherosclerosis 191 (2007) 175-181
34. Festa A., D'Agostino Jr. R., Howard G., Mykkanen L., Tracy R.P., and Haffner S.M. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102 (2000) 42-47
35. Montero I., Orbe J., Varo N., Beloqui O., Monreal J.I., Rodriguez J.A., et al. C-reactive protein induces matrix metalloproteinase-1 and -10 in human endothelial cells: implications for clinical and subclinical atherosclerosis. J Am Coll Cardiol 47 (2006) 1369-1378
36. Szekanecz Z., Shah M.R., Pearce W.H., and Koch A.E. Human atherosclerotic abdominal aortic aneurysms produce interleukin (IL)-6 and interferon-gamma but not IL-2 and IL-4: the possible role for IL-6 and interferon-gamma in vascular inflammation. Agents Actions 42 (1994) 159-162
37. Stenbaek J., Kalin B., and Swedenborg J. Growth of thrombus may be a better predictor of rupture than diameter in patients with abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 20 (2000) 466-469
38. Fontaine V., Jacob M.P., Houard X., Rossignol P., Plissonnier D., Angles-Cano E., et al. Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms. Am J Pathol 161 (2002) 1701-1710
39. Touat Z., Ollivier V., Dai J., Huisse M.G., Bezeaud A., Sebbag U., et al. Renewal of mural thrombus releases plasma markers and is involved in aortic abdominal aneurysm evolution. Am J Pathol 168 (2006) 1022-1030
40. Holmberg A., Bergqvist D., and Siegbahn A. Coagulation and fibrinolysis after open infrarenal abdominal aortic aneurysm repair in a long-term perspective. Thromb Res 96 (1999) 99-105